
19/05/2023
In recognition of International Clinical Trials Day tomorrow, 20 May we’re proud to publish our 2022 Annual Research Report showcasing the strides we’re making towards new discoveries and increasing access to emerging treatments and techniques. Last year we cared for 730 patients on active clinical trials and were involved in over 500 compounding and pharmacy trials.
Across our global network we participate in trials across medical oncology, haematology, and radiation medicine and over the next five years we will continue to grow our research capacity into new geographies and expand capabilities into molecular medicine and beyond.
Learn more about our research achievements in 2022 in the full report: https://icongroup.global/en/our-services/research/impact/annual-research-reports/ #2022